Related Experiment Video
Updated: Aug 18, 2026

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
Published on: February 2, 2022
Fibrosis and matrix metalloproteinases in rat renal allografts
Kaija A Inkinen1, Anu P Soots, Leena A Krogerus
1Transplant Unit Research Laboratory, Department of Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. kaija.inkinen@hus.fi
Abstract:
The temporal activity and gene expression of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinase (TIMP) were investigated in a rat model of chronic allograft nephropathy. Gelatinolytic activity of MMP-2 and -9 were demonstrated by zymography, and MMP-2,-9 and TIMP-3 mRNA by in situ hybridization. The generation of fibrosis was determined as total collagen content/DNA. Significantly more latent and active MMP-2, as well as latent MMP-9, were seen in allografts than in autografts. Intense MMP-2 mRNA expression was demonstrated in the allografts during the first 20 days after transplantation, located mainly in the interstitium of the kidney. In addition, some tubular cells expressed MMP-2 mRNA. After day 20, MMP-2 gene expression was faint. MMP-9 mRNA expression in allografts was located mainly in the glomerulus. TIMP-3 mRNA expression was downregulated in allografts. MMP-2, MMP-9 and TIMP-3 seem to play a critical role in the development of fibrosis in the renal allograft.
Insights
Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinase (TIMPs) are key in chronic allograft nephropathy. MMP-2 and MMP-9 activity and TIMP-3 expression correlate with renal fibrosis development.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Chronic allograft nephropathy (CAN) is a major cause of kidney transplant failure.
- Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) are implicated in tissue remodeling and fibrosis.
- Understanding the role of MMPs and TIMPs in CAN is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the temporal activity and gene expression of MMPs and TIMPs in a rat model of CAN.
- To correlate MMP and TIMP expression with the development of renal fibrosis.
Main Methods:
- Rat model of chronic allograft nephropathy.
- Zymography to assess gelatinolytic activity of MMP-2 and MMP-9.
- In situ hybridization to determine MMP-2, MMP-9, and TIMP-3 mRNA expression.
- Quantification of total collagen content/DNA to assess fibrosis.
Main Results:
- Elevated levels of latent and active MMP-2, and latent MMP-9 were observed in allografts compared to autografts.
- Intense MMP-2 mRNA expression was detected in the renal interstitium during the first 20 days post-transplantation, decreasing thereafter.
- MMP-9 mRNA was primarily localized in the glomerulus, and TIMP-3 mRNA expression was downregulated in allografts.
Conclusions:
- MMP-2, MMP-9, and TIMP-3 play significant roles in the pathogenesis of fibrosis in renal allografts.
- The temporal expression patterns suggest distinct roles for MMP-2 and MMP-9 in different renal compartments during CAN.
- Targeting MMPs and TIMPs may offer a therapeutic approach to mitigate fibrosis in CAN.
